Down syndrome: current status, challenges and future perspectives M Kazemi, M Salehi, M Kheirollahi International journal of molecular and cellular medicine 5 (3), 125, 2016 | 244 | 2016 |
Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma J Mohammadi-asl, B Larijani, Z Khorgami, SM Tavangar, V Haghpanah, ... Medical oncology 28, 1123-1128, 2011 | 68 | 2011 |
Prevalence of high‐risk human papillomavirus infection in women with ovarian endometriosis M Heidarpour, M Derakhshan, M Derakhshan‐Horeh, M Kheirollahi, ... Journal of Obstetrics and Gynaecology Research 43 (1), 135-139, 2017 | 54 | 2017 |
Brain-derived neurotrophic factor gene Val66Met polymorphism and risk of schizophrenia: a meta-analysis of case–control studies M Kheirollahi, E Kazemi, S Ashouri Cellular and Molecular Neurobiology 36, 1-10, 2016 | 54 | 2016 |
Brain tumors: Special characters for research and banking M Kheirollahi, S Dashti, Z Khalaj, F Nazemroaia, P Mahzouni Advanced biomedical research 4 (1), 4, 2015 | 48 | 2015 |
Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors M Kheirollahi, M Mehr-Azin, N Kamalian, P Mehdipour Medical Oncology 28, 7-14, 2011 | 44 | 2011 |
Meta-analysis of the association between GABA receptor polymorphisms and autism spectrum disorder (ASD) M Mahdavi, M Kheirollahi, R Riahi, F Khorvash, M Khorrami, M Mirsafaie Journal of Molecular Neuroscience 65, 1-9, 2018 | 38 | 2018 |
A Chronic Autochthonous Fifth Clade Case of Candida auris Otomycosis in Iran F Safari, M Madani, H Badali, AA Kargoshaie, H Fakhim, M Kheirollahi, ... Mycopathologia 187 (1), 121-127, 2022 | 37 | 2022 |
miR-145 and miR20a-5p potentially mediate pleiotropic effects of interferon-beta through mitogen-activated protein kinase signaling pathway in multiple sclerosis patients N Ehtesham, F Khorvash, M Kheirollahi Journal of Molecular Neuroscience 61, 16-24, 2017 | 31 | 2017 |
Telomerase activity in human brain tumors: astrocytoma and meningioma M Kheirollahi, M Mehrazin, N Kamalian, J Mohammadi-asl, P Mehdipour Cellular and molecular neurobiology 33, 569-574, 2013 | 30 | 2013 |
Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: A case‐control study P Mehdipour, S Pirouzpanah, M Kheirollahi, M Atri The breast journal 17 (1), 39-46, 2011 | 24 | 2011 |
Alterations of telomere length in human brain tumors M Kheirollahi, M Mehrazin, N Kamalian, P Mehdipour Medical Oncology 28, 864-870, 2011 | 23 | 2011 |
Identification of B and T cell epitope based peptide vaccine from IGF-1 receptor in breast cancer M Mahdavi, V Moreau, M Kheirollahi Journal of Molecular Graphics and Modelling 75, 316-321, 2017 | 20 | 2017 |
Mutation analysis of SLC3A1 and SLC7A9 genes in patients with cystinuria L Koulivand, M Mohammadi, B Ezatpour, R Salehi, S Markazi, S Dashti, ... Urolithiasis 43, 447-453, 2015 | 20 | 2015 |
Alpha-and beta-synucleins mRNA expression in lymphocytes of schizophrenia patients MR Noori-Daloii, M Kheirollahi, P Mahbod, F Mohammadi, AN Astaneh, ... Genetic testing and molecular biomarkers 14 (5), 725-729, 2010 | 16 | 2010 |
TRPC6 mutational analysis in iranian children with focal segmental glomerulosclerosis A Gheissari, R Meamar, M Kheirollahi, M Rouigari, M Dehbashi, ... Iranian Journal of Kidney Diseases 12 (6), 341, 2018 | 15 | 2018 |
MDA-7/interleukin 24 (IL-24) in tumor gene therapy: application of tumor penetrating/homing peptides for improvement of the effects M Rasoolian, M Kheirollahi, SY Hosseini Expert opinion on biological therapy 19 (3), 211-223, 2019 | 14 | 2019 |
Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders MR Noori-Daloii, M Mojarrad, A Rashidi-Nezhad, M Kheirollahi, ... Molecular biology reports 39, 2003-2010, 2012 | 14 | 2012 |
A novel mutation in SLC3A1 gene in patients with cystinuria S Markazi, M Kheirollahi, A Doosti, M Mohammadi, L Koulivand Iranian Journal of Kidney Diseases 10 (1), 44, 2016 | 13 | 2016 |
Evolutionary hypothesis of telomere length in primary breast cancer and brain tumour patients: a tracer for genomic—tumour heterogeneity and instability P Mehdipour, M Kheirollahi, M Mehrazin, N Kamalian, M Atri Cell biology international 35 (9), 915-925, 2011 | 13 | 2011 |